½ÃÀ庸°í¼­
»óǰÄÚµå
1800221

¼¼°èÀÇ µ¿¹°¿ë ±¸ÃæÁ¦ ½ÃÀå ¿¹Ãø(2025-2030³â)

Animal Parasiticides Market - Forecasts fom 2025 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Knowledge Sourcing Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 147 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ µ¿¹°¿ë ±â»ýÃæ ±¸Á¦ ½ÃÀåÀº CAGR 5.51%·Î È®´ëµÇ¾î 2025³â 131¾ï 9,000¸¸ ´Þ·¯¿¡¼­ 2030³â±îÁö 172¾ï 5,100¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

µ¿¹°¿ë ±¸ÃæÁ¦ ½ÃÀåÀº 2025³âºÎÅÍ 2030³â±îÁö ¹Ý·Áµ¿¹° »çÀ°·üÀÇ »ó½Â, µ¿¹° ÀÇ·áºñ Áõ°¡, Àμö °øÅë °¨¿°Áõ¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡ µîÀ» ¹è°æÀ¸·Î Å©°Ô ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ¹Ý·Áµ¿¹°°ú ³ó¾÷ µ¿¹°ÀÇ ¿ÜºÎ ±â»ýÃæ°ú ³»ºÎ ±â»ýÃæ °ü¸®¿¡ ÇʼöÀûÀÎ ±â»ýÃæ ±¸Á¦Á¦´Â µ¿¹°ÀÇ °Ç°­À» ÁõÁøÇϰí Áúº´ °¨¿°À» ¿¹¹æÇÏ´Â ¿ªÇÒÀ» Çϱ⠶§¹®¿¡ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¾ö°ÝÇÑ ±ÔÁ¦ Á¤Ã¥ÀÌ °úÁ¦°¡ µÇ°í ÀÖÁö¸¸, Á¦Ç° °³Ã´¿¡ À־ÀÇ ±â¼ú Çõ½Å°ú µ¿¹° º¹Áö¸¦ ÃßÁøÇÏ´Â Á¤ºÎÀÇ ´ëó·ÎºÎÅÍ ÇýÅÃÀ» ¹Þ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

µ¿¹° ±â»ýÃæ ±¸Á¦ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ¼¼°è ¹Ý·Áµ¿¹° »çÀ°ÀÇ ±ÞÁõÀ̸ç, ƯÈ÷ µµ½Ã Áö¿ª¿¡¼­´Â °³, °í¾çÀÌ¿Í °°Àº ¹Ý·Áµ¿¹°ÀÇ °¡Ä¡°¡ Á¡Á¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ µ¿ÇâÀº ¹Ý·Áµ¿¹°ÀÇ °Ç°­À» º¸ÀåÇÏ°í »ç¶÷¿¡°Ô °¨¿°µÇ´Â Áúº´À» ¿¹¹æÇϱâ À§ÇØ È¿°úÀûÀÎ ±â»ýÃæ ±¸Á¦Á¦ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° ÁÖÀΰú Ãà»ê¾÷ÀÚ°¡ µ¿¹°ÀÇ º¹Áö¸¦ °³¼±Çϱâ À§ÇØ Ã·´Ü Ä¡·á¿¡ ÅõÀÚÇϰí Àֱ⠶§¹®¿¡ ƯÈ÷ ÷´Ü Áö¿ª¿¡¼­ µ¿¹° °Ç°­¿¡ ´ëÇÑ ÁöÃâÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÌ ½ÃÀå ¼ºÀåÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎ¿Í µ¿¹° ¾ÖÈ£ ´ÜüÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÀÇÇØ Áö¿øµÇ´Â µ¿¹° Àü¿°º´¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡µµ Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Ä·ÆäÀÎÀº º­·è, Áøµå±â, È¸Ãæ ¹× ±âŸ ±â»ýÃæ¿¡ ÀÇÇØ À¯¹ßµÇ´Â Áúº´À» Á¦¾îÇÏ´Â µ¥ ±â»ýÃæ ±¸Á¦Á¦ÀÇ Á߿伺À» °­Á¶ÇÕ´Ï´Ù. ¶ÇÇÑ, ¹Ý·Áµ¿¹°ÀÇ Áúº´ °ü¸®¸¦ °­È­Çϱâ À§ÇØ °í¾ÈµÈ Çõ½ÅÀûÀÎ ¿ÜºÎ ±â»ýÃæ ±¸Á¦Á¦ÀÇ °³¹ßÀº º¸´Ù È¿°úÀûÀ̰í Àû±ØÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

µ¿¹°¿ë ±¸ÃæÁ¦ ½ÃÀåÀº Á¦Ç° ½ÂÀο¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ Á¤Ã¥¿¡ µû¸¥ ¹®Á¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦´Â ¾ÈÀü¼º°ú È¿´ÉÀ» È®º¸Çϱâ À§ÇÑ °ÍÀ̹ǷΠ½Å±Ô ±¸ÃæÁ¦ ½ÃÀå ÁøÀÔÀ» Áö¿¬½ÃŰ°í °³¹ß ºñ¿ë°ú °³¹ß ±â°£À» Áõ°¡½Ãų ¼ö ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ Áö¿ª Ç¥ÁØÀ» ÁؼöÇϸé Á¦Á¶¾÷ü, ƯÈ÷ Áß¼Ò±â¾÷ ½ÃÀå ÁøÀÔÀÌ ´õ¿í º¹ÀâÇØÁö°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ÷´Ü ±¸ÃæÁ¦´Â °í°¡À̱⠶§¹®¿¡ ½ÅÈï±¹ ½ÃÀå µî °¡°Ý¿¡ ¹Î°¨ÇÑ ½ÃÀå¿¡¼­´Â µµÀÔÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀ» À§Çؼ­´Â ±ÔÁ¦ ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÏ°í ºñ¿ë È¿À²ÀûÀÎ ±â¼ú Çõ½ÅÀ» ÅëÇØ ÀÌ·¯ÇÑ °úÁ¦¸¦ ÇØ°áÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå ÇöȲ

  • ½ÃÀå °³¿ä
  • ½ÃÀåÀÇ Á¤ÀÇ
  • Á¶»ç ¹üÀ§
  • ½ÃÀå ¼¼ºÐÈ­

Á¦3Àå ºñÁî´Ï½º »óȲ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • Porter's Five Forces ºÐ¼®
  • ¾÷°è ¹ë·ùüÀÎ ºÐ¼®
  • Á¤Ã¥ ¹× ±ÔÁ¤
  • Àü·«Àû Á¦¾È

Á¦4Àå ±â¼ú Àü¸Á

Á¦5Àå µ¿¹°¿ë ±¸ÃæÁ¦ ½ÃÀå : Á¦Ç° À¯Çüº°

  • ¼Ò°³
  • ¿ÜºÎ ±â»ýÃæ ±¸ÃæÁ¦
  • ³»ºÎ ±â»ýÃæ ±¸ÃæÁ¦
  • ³»¿ÜºÎ ±â»ýÃâ ±¸ÃæÁ¦

Á¦6Àå µ¿¹°¿ë ±¸ÃæÁ¦ ½ÃÀå : ±â»ýÃæ À¯Çüº°

  • ¼Ò°³
  • ³»ºÎ
  • ¿ÜºÎ
    • Áøµå±â
    • º­·è
    • ±âŸ

Á¦7Àå µ¿¹°¿ë ±¸ÃæÁ¦ ½ÃÀå : Åõ¿© ¹æ¹ýº°

  • ¼Ò°³
  • °æ±¸
  • ÁÖ»çÁ¦

Á¦8Àå µ¿¹°¿ë ±¸ÃæÁ¦ ½ÃÀå : µ¿¹° À¯Çüº°

  • ¼Ò°³
  • ¹Ý·Áµ¿¹°
  • °¡Ãà
    • ¼Ò
    • °¡±Ý
    • µÅÁö
    • ±âŸ

Á¦9Àå µ¿¹°¿ë ±¸ÃæÁ¦ ½ÃÀå : Áö¿ªº°

  • ¼Ò°³
  • ºÏ¹Ì
    • Á¦Ç° À¯Çüº°
    • ±â»ýÃæ À¯Çüº°
    • Åõ¿© ¹æ¹ýº°
    • µ¿¹° À¯Çüº°
    • ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
  • ³²¹Ì
    • Á¦Ç° À¯Çüº°
    • ±â»ýÃæ À¯Çüº°
    • Åõ¿© ¹æ¹ýº°
    • µ¿¹° À¯Çüº°
    • ±¹°¡º°
      • ºê¶óÁú
      • ¾Æ¸£ÇîÆ¼³ª
      • ±âŸ
  • À¯·´
    • Á¦Ç° À¯Çüº°
    • ±â»ýÃæ À¯Çüº°
    • Åõ¿© ¹æ¹ýº°
    • µ¿¹° À¯Çüº°
    • ±¹°¡º°
      • µ¶ÀÏ
      • ÇÁ¶û½º
      • ¿µ±¹
      • ½ºÆäÀÎ
      • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Á¦Ç° À¯Çüº°
    • ±â»ýÃæ À¯Çüº°
    • Åõ¿© ¹æ¹ýº°
    • µ¿¹° À¯Çüº°
    • ±¹°¡º°
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
      • À̽º¶ó¿¤
      • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Á¦Ç° À¯Çüº°
    • ±â»ýÃæ À¯Çüº°
    • Åõ¿© ¹æ¹ýº°
    • µ¿¹° À¯Çüº°
    • ±¹°¡º°
      • Áß±¹
      • Àεµ
      • ÀϺ»
      • Çѱ¹
      • Àεµ³×½Ã¾Æ
      • ű¹
      • ±âŸ

Á¦10Àå °æÀï ȯ°æ°ú ºÐ¼®

  • ÁÖ¿ä ±â¾÷°ú Àü·« ºÐ¼®
  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • ÇÕº´, Àμö, ÇÕÀÇ ¹× Çù¾÷
  • °æÀï ´ë½Ãº¸µå

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Boehringer Ingelheim GmbH
  • Elanco
  • Virbac Corporation
  • Merck & Co., Inc.
  • Zoetis
  • Vetoquinol SA
  • Ceva Sante Animale
  • Perrigo Company Plc,
  • Norbrook Laboratories
  • Bimeda Inc.

Á¦12Àå ºÎ·Ï

  • ÅëÈ­
  • ÀüÁ¦Á¶°Ç
  • ±âÁØ¿¬µµ°ú ¿¹Ãø¿¬µµÀÇ Å¸ÀÓ¶óÀÎ
  • ÀÌÇØ °ü°èÀÚ¿¡°Ô À־ÀÇ ÁÖ¿ä ÀÌÁ¡
  • Á¶»ç ¹æ¹ý
  • ¾à¾î
JHS 25.09.03

The animal parasiticides marketis expected to grow from USD13.190 billion in 2025 to USD17.251 billion in 2030, at a CAGR of 5.51%.

The animal parasiticides market is poised for significant growth from 2025 to 2030, driven by rising pet adoption, increasing animal health expenditure, and growing awareness of zoonotic diseases. Parasiticides, critical for managing ecto- and endoparasites in companion and agricultural animals, are seeing heightened demand due to their role in enhancing animal health and preventing disease transmission. The market benefits from innovations in product development and government initiatives promoting animal welfare, though stringent regulatory policies pose challenges.

Market Drivers

The primary driver of the animal parasiticides market is the global surge in pet adoption, particularly in urban areas, where companion animals like dogs and cats are increasingly valued. This trend has amplified the demand for effective parasiticides to ensure pet health and prevent diseases transmissible to humans. Rising animal health expenditure, especially in developed regions, further fuels market growth, as pet owners and livestock producers invest in advanced treatments to improve animal welfare. Growing awareness of animal-transmitted diseases, supported by initiatives from governments and animal welfare organizations, is another key factor. These campaigns emphasize the importance of parasiticides in controlling diseases caused by fleas, ticks, worms, and other parasites. Additionally, the development of innovative ectoparasiticides, designed to enhance disease management in companion animals, is driving market expansion by offering more effective and targeted solutions.

Market Restraints

The animal parasiticides market faces challenges due to stringent regulatory policies governing product approvals. These regulations, aimed at ensuring safety and efficacy, can delay market entry for new parasiticides, increasing development costs and timelines. Compliance with diverse regional standards further complicates market access for manufacturers, particularly smaller players. Additionally, the high cost of advanced parasiticides may limit adoption in price-sensitive markets, such as developing regions, where affordability is a key concern. Addressing these challenges through streamlined regulatory processes and cost-effective innovations will be essential for sustained market growth.

Market Segmentation

By Product Type

The market is segmented into ectoparasiticides, endoparasiticides, and endectocides. Ectoparasiticides, targeting external parasites like fleas and ticks, hold a significant share due to their widespread use in companion animals. Endoparasiticides, which address internal parasites like worms, are critical for both companion and agricultural animals. Endectocides, offering dual action against internal and external parasites, are gaining traction for their versatility and efficiency.

By Animal Type

The market serves companion animals (e.g., dogs, cats) and agricultural animals (e.g., cattle, poultry). The companion animal segment dominates, driven by rising pet ownership and increased spending on pet healthcare. The agricultural animal segment is also significant, as parasiticides are essential for maintaining livestock health and productivity, particularly in regions with intensive farming.

By Geography

The market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America leads, driven by high animal health expenditure, particularly in the United States, and widespread pet adoption. The region's advanced veterinary infrastructure and effective disease management practices further support market dominance. Asia-Pacific is expected to grow rapidly, fueled by increasing pet ownership, rising livestock production, and growing awareness of zoonotic diseases in countries like China and India. Europe, South America, and the Middle East and Africa are also poised for growth, supported by improving veterinary services and regulatory frameworks.

Key Industry Players

The competitive landscape includes leading companies focused on innovation and market expansion. These players are investing in research and development to create advanced parasiticides and strengthen their market positions through strategic partnerships and product launches.

The animal parasiticides market is set for lucrative growth from 2025 to 2030, driven by rising pet adoption, increasing animal health expenditure, and growing awareness of zoonotic diseases. Despite challenges from stringent regulations and high costs, the market's outlook remains positive, particularly in North America and Asia-Pacific. Industry players must focus on innovative, cost-effective solutions and regulatory compliance to capitalize on the growing demand for parasiticides in both companion and agricultural animal sectors.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

The animal parasiticides market is analyzed into the following segments:

By Product Type

  • Ectoparasiticides
  • Endoparasiticides
  • Endectocides

By Parasite Type

  • External
  • Internal

By Mode of Administration

  • Oral
  • Injectables

By Animal Type

  • Companion Animal
  • Livestock Animals

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ANIMAL PARASITICIDES MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Ectoparasiticides
  • 5.3. Endoparasiticides
  • 5.4. Endectocides

6. ANIMAL PARASITICIDES MARKET BY PARASITE TYPE

  • 6.1. Introduction
  • 6.2. Internal
  • 6.3. External
    • 6.3.1. Ticks
    • 6.3.2. Fleas
    • 6.3.3. Others

7. ANIMAL PARASITICIDES MARKET BY MODE OF ADMINISTRATION

  • 7.1. Introduction
  • 7.2. Oral
  • 7.3. Injectable

8. ANIMAL PARASITICIDES MARKET BY ANIMAL TYPE

  • 8.1. Introduction
  • 8.2. Companion Animals
  • 8.3. Livestock Animals
    • 8.3.1. Cattle
    • 8.3.2. Poultry
    • 8.3.3. Swine
    • 8.3.4. Others

9. ANIMAL PARASITICIDES MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Product Type
    • 9.2.2. By Parasite Type
    • 9.2.3. By Mode of Administration
    • 9.2.4. By Animal Type
    • 9.2.5. By Country
      • 9.2.5.1. USA
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Product Type
    • 9.3.2. By Parasite Type
    • 9.3.3. By Mode of Administration
    • 9.3.4. By Animal Type
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Product Type
    • 9.4.2. By Parasite Type
    • 9.4.3. By Mode of Administration
    • 9.4.4. By Animal Type
    • 9.4.5. By Country
      • 9.4.5.1. Germany
      • 9.4.5.2. France
      • 9.4.5.3. United Kingdom
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Product Type
    • 9.5.2. By Parasite Type
    • 9.5.3. By Mode of Administration
    • 9.5.4. By Animal Type
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Israel
      • 9.5.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Product Type
    • 9.6.2. By Parasite Type
    • 9.6.3. By Mode of Administration
    • 9.6.4. By Animal Type
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. India
      • 9.6.5.3. Japan
      • 9.6.5.4. South Korea
      • 9.6.5.5. Indonesia
      • 9.6.5.6. Thailand
      • 9.6.5.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Boehringer Ingelheim GmbH
  • 11.2. Elanco
  • 11.3. Virbac Corporation
  • 11.4. Merck & Co., Inc.
  • 11.5. Zoetis
  • 11.6. Vetoquinol S.A.
  • 11.7. Ceva Sante Animale
  • 11.8. Perrigo Company Plc,
  • 11.9. Norbrook Laboratories
  • 11.10. Bimeda Inc.

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦